33 Dynamic monitoring of response to immune checkpoint blockade through deep-learning empowered ultra-sensitive liquid biopsy in melanoma

33 Dynamic monitoring of response to immune checkpoint blockade through deep-learning empowered ultra-sensitive liquid biopsy in melanoma

Bibliographic Details
Main Authors:	Jedd Wolchok, Adam Widman, Cole Khamnei, Jake Bass, Will Liao, Minita Shah, Nicolas Robine, Margaret Callahan, Dan Landau
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
by: Krista Dubin, et al.
Published: (2016-02-01)

CTLA-4 and PD-1 pathway Blockade : Combinations in the Clinic
by: Margaret Kathleen Callahan, et al.
Published: (2015-01-01)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
by: Anja Wessely, et al.
Published: (2020-01-01)

Predictors of responses to immune checkpoint blockade in advanced melanoma
by: N. Jacquelot, et al.
Published: (2017-09-01)

Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy
by: Anastasia Prokopi, et al.
Published: (2021-01-01)

Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patients
by: Kaat de Jonge, et al.
Published: (2021-01-01)

Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
by: Beckey Trinh, et al.
Published: (2019-02-01)

Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis
by: Chen, X., et al.
Published: (2022)

Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade
by: Elizabeth I. Buchbinder, et al.
Published: (2021-04-01)

Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors
by: Maha Mamoor, et al.
Published: (2020-06-01)

Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma
by: Nicolas Jacquelot, et al.
Published: (2017-08-01)

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
by: Johannes Griss, et al.
Published: (2019-09-01)

Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
by: Meihua Wang, et al.
Published: (2019-02-01)

TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
by: Matthew J. Reilley, et al.
Published: (2019-11-01)

MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma
by: Ricardo A. de Azevedo, et al.
Published: (2020-01-01)

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
by: Manisha Singh, et al.
Published: (2017-11-01)

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
by: Markus V. Heppt, et al.
Published: (2019-11-01)

Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
by: Thilo Gambichler, et al.
Published: (2017-05-01)

Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?
by: Jake S. O’Donnell, et al.
Published: (2016-10-01)

Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
by: Paolo A. Ascierto, et al.
Published: (2019-03-01)

Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators
by: Hwa Kyung Byun, et al.
Published: (2021-05-01)

Neutrophils in the era of immune checkpoint blockade
by: Solange Peters, et al.
Published: (2021-07-01)

Immune-Checkpoint Blockade Therapy in Lymphoma
by: Ayumi Kuzume, et al.
Published: (2020-07-01)

Progressive choroidal thinning (leptochoroid) and fundus depigmentation associated with checkpoint inhibitors
by: Julia Canestraro, et al.
Published: (2020-09-01)

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis
by: Elias A. T. Koch, et al.
Published: (2021-07-01)

Enhanced Antitumor Response to Immune Checkpoint Blockade Exerted by Cisplatin-Induced Mutagenesis in a Murine Melanoma Model
by: Falih M. Gorgun, et al.
Published: (2021-07-01)

Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade
by: Christopher A Natale, et al.
Published: (2018-01-01)

657 Interleukin-6 receptor blockade for management of immune checkpoint inhibitor related adverse events in patients with melanoma
by: Adi Diab, et al.
Published: (2020-11-01)

838 Phenotypic and functional signatures of peripheral and tumor-resident γδ T cells are informative for outcome of checkpoint blockade in melanoma
by: Graham Pawelec, et al.
Published: (2020-11-01)

Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom control
by: Michael S. Hughes, et al.
Published: (2019-09-01)

CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015-10-01)

Rethinking immune checkpoint blockade: ‘Beyond the T cell’
by: Xiuting Liu, et al.
Published: (2021-01-01)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
by: Jan Christoph Banck, et al.
Published: (2021-03-01)

Acquired Resistance to Immune Checkpoint Blockade Therapies
by: Xianda Zhao, et al.
Published: (2020-05-01)

Gastric Cancer in the Era of Immune Checkpoint Blockade
by: Lucía Figueroa-Protti, et al.
Published: (2019-01-01)

Smoldering myocarditis following immune checkpoint blockade
by: Timothy G. Norwood, et al.
Published: (2017-11-01)

Checkpoint Blockade in Cancer Immunotherapy: Squaring the Circle
by: Maria A.V. Marzolini, et al.
Published: (2015-03-01)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
by: Brian J. Ahn, et al.
Published: (2013-11-01)

Predictive biomarkers for tumor immune checkpoint blockade
by: Tong M, et al.
Published: (2018-10-01)

The role of neoantigen in immune checkpoint blockade therapy
by: Ming Yi, et al.
Published: (2018-11-01)